ArticleThe Lancet. Microbe2023

Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply.

Daniel H F Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.